Drysdale, Myriam http://orcid.org/0000-0002-8994-2816
Tibble, Holly http://orcid.org/0000-0001-7169-4087
Patel, Vishal http://orcid.org/0000-0002-1517-4148
Gibbons, Daniel C. http://orcid.org/0000-0002-3769-9535
Lloyd, Emily J.
Kerr, William
Macdonald, Calum http://orcid.org/0000-0001-7857-9188
Birch, Helen J. http://orcid.org/0000-0002-4924-4810
Sheikh, Aziz http://orcid.org/0000-0001-7022-3056
Funding for this research was provided by:
GSK in collaboration with Vir Biotechnology, Inc
Article History
Received: 23 August 2023
Accepted: 27 June 2024
First Online: 4 July 2024
Declarations
:
: This study received data access and processing approval from the Public Benefit and Privacy Panel for Health and Social Care, NHS Scotland on November 9, 2022. We complied with all applicable laws regarding subject privacy. No direct subject contact or primary collection of individual human subject data occurred as part of this study; therefore, informed consent, ethics committee, or IRB approval were not required, as determined by the NHS Health Research Authority Research Ethics Committee decision tool (). Study results were reported in tabular form and aggregate analyses that omitted subject identification. Publications, reports or any other research outputs do not include subject identifiers and low patient numbers were suppressed.
: Not applicable.
: MD, DCG, EJL, WK, and HJB and are employees of, and/or shareholders in, GSK. VP was an employee of GSK at the time of the study and is now an employee of KVM Analytics. HT, CM, and AS are employees of the University of Edinburgh, which received funding from GSK and Vir Biotechnology, Inc. to conduct the study. AS has also served on a number of Scottish Government and UK Government COVID-19 advisory groups, all of which have been unremunerated.